Can euphoria be bad?

Journal of the American College of Cardiology

Volumn 41, Issue 8, 2003, Pages 1289-1292

  Berger, Peter B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; EDITORIAL; ELUTION; EQUIPMENT DESIGN; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; TREATMENT OUTCOME;

EID: 0037393001     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00128-1     Document Type: Editorial

References (19)

1. Baim DS, Cutlip DE, Midei M, et al. Final results of a randomized trial comparing the Multi-Link stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001;87:157-62.
2. Heuser R, Kuntz R, Lansky A, et al. Six-month clinical and angiographic results of the SMART trial (abstr). J Am Coll Cardiol 1998;31:64A.
3. Baim D, Cutlip D, O'Shaughnessy C, A randomized trial comparing the NIR stent to the Palmaz-Schatz stent in native coronary lesions. Am J Cardiol 2003. In Press.
4. Han R, Schwartz R, Mann T, et al. Comparative efficacy of self-expanding and balloon expandable stents for the reduction of restenosis (abstr). J Am Coll Cardiol 1998;96:314A.
5. Holmes D, Lansky A, Kuntz R, et al. The Paragon stent study: a randomized trial of a new martinsitic nitinol stent versus the Palmaz-Schatz (PS) stent for the treatment of complex native coronary arterial lesions. Am J Cardiol 2003. In Press.
6. Lansky AJ, Roubin GS, O'Shaughnessy CD, et al. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation 2000;102:1364-8.
7. Kastrati A, Dirschinger J, Boeckstegers P, et al. Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Cathet Cardiovasc Interv 2000;50:290-7.
8. Kastrati A, Schomig A, Dirschinger J, et al. Increased risk of restenosis after placement of gold-coated stents. Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000;101:2478-83.
9. Park SJ, Lee CW, Hong MK, et al. Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease. Am J Cardiol 2002;89:872-5.
10. Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary Stenting and Angiographic Results-Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) trial. Circulation 2001;103:2816-21.
11. Pache J, Kastrati K, Mehilli J, et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO 2) trial. J Am Coll Cardiol 2003;41:1283-8.
12. Stone GW, Grines CL, Cox D, et al. The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-66.
13. Emanuelsson H, Serruys PW, van der Giessen WJ, et al. Clinical and angiographic results with the Multi-Link coronary stent system - The West European Stent Trial (WEST). J Invasive Cardiol 1998;10 Suppl B:12B-9B.
14. Serruys PW, van der Giessen W, Garcia E, et al. Clinical and angiographic results with the Multilink coronary stent implanted under intravascular ultrasound guidance (West 2 Study). J Invasive Cardiol 1998;10 Suppl B:20B-7B.
15. Zidar JP. The VENUS trial: a multicenter registry of the Cordis Bx Velocity stent. Presented at: Transcatheter Therapeutics meeting, September 2000.
16. Serruys P, Ijsselmuiden S, van Hout B, et al. Safety and efficacy of direct coronary stenting with a new balloon-expandable stent mounted on a rapid exchange delivery system, compared with stenting preceded by balloon dilatatiaon. The VELVET trial. J Invasive Cardiol 2003. In Press.
17. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizarion. N Engl J Med 2002;346:1773-80.
18. Leon M. Results of the first 400 patients enrolled in the SIRIUS trial. Presented at the EuroPCR meeting; May 2002; Paris, France.
19. Sousa JE, Costa MA, Abizaid A, et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001;103:192-5.